Tyrosine kinase mutations in gastrointestinal stromal tumors in a nation-wide study in Iceland.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationAMPIS. 2010, 118(9):648-56
AbstractGastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. It is characterized by activating mutations in the tyrosine kinase genes c-kit or PDGFRA. This study examined the mutation rate and type in a population-based material. All gastrointestinal mesenchymal tumors over the years 1990-2004 were evaluated and GIST tumors identified using immunohistochemistry (c-kit) and conventional pathologic parameters. Paraffin sections from all tumors were subjected to mutation analysis on exons 9, 11, 13 and 17 of the c-kit gene and exons 12 and 18 of the PDGFRA gene. To screen for mutations, we used a highly sensitive conformation-sensitive gel electrophoresis (CSGE) and to define the mutated alleles, we employed direct automated DNA sequencing. All c-kit-positive gastrointestinal mesenchymal tumors were entered into the study. Fifty-six tumors from 55 patients were analyzed. Mutations were found in 52 tumors representing a 92.9% mutational rate. Most of the mutations were found in c-kit exon 11 (76.8%), followed by c-kit exon 9 (10.7%). PDGFRA mutations were only found in three tumors. No correlation of mutation type with biologic behavior was found. This population-based study, using a sensitive CSGE method, identifies mutations in the great majority of patients with GIST.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Mutations in gastrointestinal stromal tumors--a population-based study from Northern Norway.
- Authors: Steigen SE, Eide TJ, Wasag B, Lasota J, Miettinen M
- Issue date: 2007 Apr
- Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study.
- Authors: Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR
- Issue date: 2005 Apr
- The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
- Authors: Du CY, Shi YQ, Zhou Y, Fu H, Zhao G
- Issue date: 2008 Sep 1
- Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site.
- Authors: Wasag B, Debiec-Rychter M, Pauwels P, Stul M, Vranckx H, Oosterom AV, Hagemeijer A, Sciot R
- Issue date: 2004 Aug
- Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
- Authors: Andersson J, Bümming P, Meis-Kindblom JM, Sihto H, Nupponen N, Joensuu H, Odén A, Gustavsson B, Kindblom LG, Nilsson B
- Issue date: 2006 May